Sign in

Collins Genomics Lab

@collinsgenomics.bsky.social
79 followers 404 following 20 posts

Working to realize the promise of human genomics to better predict, prevent, and treat cancer. For more info: labs.dana-farber.org/collins-genomi…

PostsRepliesMedia
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
My 2🪙 in closing: Rigorous, large-scale WGS + analyses beyond coding SNVs/indels will be critical for 1. Fully understanding cancer susceptibility (esp. early-onset), and 2. Guiding evidence-based screening strategies for #earlydetection 15/15
000
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
And that's a wrap! These studies are the outriders of a wave of germline projects coming down the pipe Exciting time to be in the field. HUGE thanks to collaborators, funders, and patients who made this possible. Want to learn more? Check out our lab: labs.dana-farber.org/collins-geno... 14/15
labs.dana-farber.org
Home | Collins Genomics Lab at Dana-Farber Cancer Institute
100
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
Neither of these SVs signals were seen in the older never-smoker cohort Yet both are similar to what we reported last year in pediatric cancers: www.science.org/doi/10.1126/... Could this imply a uniquely impt. role for rare germline SVs in early-onset, rearranged cancers?? 🤔 13/15
science.org
Rare germline structural variants increase risk for pediatric solid tumors
Pediatric solid tumors are a leading cause of childhood disease mortality. In this work, we examined germline structural variants (SVs) as risk factors for pediatric extracranial solid tumors using ge...
100
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
2. Another appearance from rare germline SVs! Two main signals: i. SVs disrupting lung-expressed, mutationally constrained genes ii. Very large germline deletions in pts w/fusion+ tumors 12/15
100
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
Lots of findings in this one, too. I'll highlight two key discoveries: 1. Paired germline + somatic analyses reveals rare variants predispose to *specific molecular subtypes* of young LUAD Germline IREB2 -> fusion-driven lung Germline SMAD4 -> non-fusion-driven 🤔 11/15
100
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
Jackie + Pasi recruited & WGS'ed 251 early-onset lung cancer patients Our team led computational analysis of these patients jointly with: + 196 lung patients with no smoking history (comparison pop.) + 1,883 cancer-free controls 10/15
110
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
Moving on to our second study: Amazing translational collab. w/Jackie LoPiccolo, Pasi Janne + @sashagusevposts.bsky.social to study a rare but v impt. patient population: people Dx'ed with #lungcancer before 45 years old www.medrxiv.org/content/10.6... 9/15
medrxiv.org
Germline determinants of risk and molecular subtype in young-onset lung cancer
Young-onset lung cancer is enriched for never-smoking and oncogene-driven tumors, yet its inherited genetic basis remains poorly defined. We performed germline whole-genome sequencing in 251 young-ons...
130
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
3. Gene discovery in cancer is not finished, even for highly studied cancers! Noah found a rare 5' UTR variant in BRAT1 (BRCA/ATM-related gene) that confers 10x odds of breast cancer CRISPR modeling by Wenbin Mei + JT Neal @broadinstitute.org confirmed UTR splice effect 8/15
100
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
In fact, large % of familial cancers had PRS effects as strong as rare pathogenic variants Ex: 20% of familial breast cases had PRS as strong as path. CHEK2 variant 😮 🩺 insight: we clearly need to be thinking beyond rare variants even for patients with strong FHx 7/15
100
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
2. Despite enriching for presumably Mendelian inheritance, common polygenic risk #PRS was elevated in most cancer types and tracked with specific family histories 🤯 Turns out even familial cancers can (should?) be viewed as complex traits! 6/15
100
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
Lots of cool findings! Here are three of my favorites: 1. Rare SVs enriched in known cancer genes, like 6kb single-exon duplication in BRCA1 in familial breast cancer or 20kb deletion of MSH2 in familial colon cancer👀 5/15
100
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
We asked: why do these families have such strong burden of cancer? Using whole-genome sequencing 🧬, Noah systematically tested several possibilities Takeaway: we were able to explain ~11% of all cases by genetic factors *beyond* recognized pathogenic germline variants 4/15
100
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
Ok, on to the science! Our first one was led by Noah Fields, who used the @AllofUsResearch cohort to ID 1,496 cancer patients with 3+ affected relatives but no recognized pathogenic variant. www.medrxiv.org/content/10.6... 3/15
medrxiv.org
Diverse mediators of cancer predisposition uncovered by germline whole genome sequencing of unexplained familial cancers
Cancer frequently clusters in families due to shared environment and genetics. However, many familial cancer cases lack a clinically recognized pathogenic germline variant (PGV). We analyzed germline ...
110
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
But first, a sentimental note: These two are unusually special to me. They spanned the end of my postdoc w/@vanallenlab.bsky.social into the first year of my new lab @danafarber.bsky.social with big 💪🧠 from some of our first lab members, Noah Fields + Carter Nakagawa 2/15
labs.dana-farber.org
People | Collins Genomics Lab at Dana-Farber Cancer Institute
100
Collins Genomics Lab @collinsgenomics.bsky.social · 10/07/2026
📣Delighted to share two new studies from our team using germline genome sequencing 🧬 to understand #cancer #predisposition! Interested? 🧵👇 for details 1/15
111
Collins Genomics Lab @collinsgenomics.bsky.social · 06/03/2026
If you have a strong computational background and experience in functional genomics or cancer biology, we’d love to hear from you. Apply here: careers.dana-farber.org/job/637/post...
careers.dana-farber.org
Fellowships Job: Postdoctoral Research Fellow - Computational Biologist at Dana-Farber Cancer Institute in 450 Brookline Ave, BOSTON, MA
Postdoctoral Research Fellow - Computational Biologist job
010
Collins Genomics Lab @collinsgenomics.bsky.social · 06/03/2026
We're looking for someone to lead the integration of tens of thousands of germline genomes with tumor/normal transcriptomes and clinical data tackle a big question in cancer genetics: how does each patient's unique inherited genome influence tumor initiation and early evolution?
120
Collins Genomics Lab @collinsgenomics.bsky.social · 06/03/2026
📣 We’re hiring a computational genomics postdoc! 📣 Our lab at @danafarber.bsky.social is looking for a postdoctoral fellow — details in 🧵👇
100
Collins Genomics Lab @collinsgenomics.bsky.social · 16/09/2025
One in pediatric cancers (joint with Riaz Gillani's lab @DFCI / @bostonchildrens.bsky.social): careers.dana-farber.org/job/12186/po... Come work with us at the intersection of cutting-edge human genomics, cancer predisposition, and tumorigenesis!
careers.dana-farber.org
Research Laboratory Job: Postdoctoral Computational Biologist in Cancer Genetics at Dana-Farber Cancer Institute in 450 Brookline Ave, Boston, MA
Postdoctoral Computational Biologist in Cancer Genetics job
000
Collins Genomics Lab @collinsgenomics.bsky.social · 16/09/2025
📢We are hiring! The Collins Genomics Lab @danafarber.bsky.social is looking to hire two postdoctoral fellows One in hereditary and early-onset adult cancers: careers.dana-farber.org/job/12158/po... 1/2🧵
careers.dana-farber.org
Research Laboratory Job: Postdoctoral Research Fellow - Computational Biologist at Dana-Farber Cancer Institute in 450 Brookline Ave, Boston, MA
Postdoctoral Research Fellow - Computational Biologist job
122